Macrogen, Inc. (KOSDAQ:038290)
16,270
-630 (-3.73%)
Apr 29, 2026, 11:18 AM KST
Macrogen Revenue
In the year 2025, Macrogen had annual revenue of 195.27B KRW with 43.82% growth. Macrogen had revenue of 56.26B in the quarter ending December 31, 2025, with 37.31% growth.
Revenue
195.27B
Revenue Growth
+43.82%
P/S Ratio
0.94
Revenue / Employee
411.09M
Employees
475
Market Cap
183.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 195.27B | 59.49B | 43.82% |
| Dec 31, 2024 | 135.78B | 2.97B | 2.24% |
| Dec 31, 2023 | 132.80B | -5.81B | -4.19% |
| Dec 31, 2022 | 138.62B | 9.44B | 7.31% |
| Dec 31, 2021 | 129.17B | 16.57B | 14.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EASY BIO,Inc. | 476.94B |
| Bioneer | 330.11B |
| JETEMA, | 76.90B |
| HLB Therapeutics | 69.56B |
| Amicogen | 41.98B |
| Genexine | 5.81B |
| iNtRON Biotechnology | 5.74B |
| ENCell | 5.26B |